These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35129252)

  • 1. Multimodal data integration via mediation analysis with high-dimensional exposures and mediators.
    Zhao Y; Li L;
    Hum Brain Mapp; 2022 Jun; 43(8):2519-2533. PubMed ID: 35129252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal neuroimaging data integration and pathway analysis.
    Zhao Y; Li L; Caffo BS
    Biometrics; 2021 Sep; 77(3):879-889. PubMed ID: 32789850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial least squares for functional joint models with applications to the Alzheimer's disease neuroimaging initiative study.
    Wang Y; Ibrahim JG; Zhu H
    Biometrics; 2020 Dec; 76(4):1109-1119. PubMed ID: 32010968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaussian discriminative component analysis for early detection of Alzheimer's disease: A supervised dimensionality reduction algorithm.
    Fang C; Li C; Forouzannezhad P; Cabrerizo M; Curiel RE; Loewenstein D; Duara R; Adjouadi M;
    J Neurosci Methods; 2020 Oct; 344():108856. PubMed ID: 32663548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Pathway Inference for Multimodal Neuroimaging Analysis.
    Li L; Shi C; Guo T; Jagust WJ
    Stat; 2022 Dec; 11(1):. PubMed ID: 35450402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical inference for linear mediation models with high-dimensional mediators and application to studying stock reaction to COVID-19 pandemic.
    Guo X; Li R; Liu J; Zeng M
    J Econom; 2023 Jul; 235(1):166-179. PubMed ID: 36568314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology steered stratification network for subtype identification in Alzheimer's disease.
    Xu E; Zhang J; Li J; Song Q; Yang D; Wu G; Chen M
    Med Phys; 2024 Feb; 51(2):1190-1202. PubMed ID: 37522278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
    Abdelaziz M; Wang T; Elazab A
    J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian hierarchical models for high-dimensional mediation analysis with coordinated selection of correlated mediators.
    Song Y; Zhou X; Kang J; Aung MT; Zhang M; Zhao W; Needham BL; Kardia SLR; Liu Y; Meeker JD; Smith JA; Mukherjee B
    Stat Med; 2021 Nov; 40(27):6038-6056. PubMed ID: 34404112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zu C; Jie B; Liu M; Chen S; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Dec; 10(4):1148-1159. PubMed ID: 26572145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DP2LM: leveraging deep learning approach for estimation and hypothesis testing on mediation effects with high-dimensional mediators and complex confounders.
    Wang S; Huang Y
    Biostatistics; 2024 Jul; 25(3):818-832. PubMed ID: 38330064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penalized decomposition using residuals (PeDecURe) for feature extraction in the presence of nuisance variables.
    Weinstein SM; Davatzikos C; Doshi J; Linn KA; Shinohara RT;
    Biostatistics; 2023 Jul; 24(3):653-668. PubMed ID: 35950944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous confidence corridors for mean functions in functional data analysis of imaging data.
    Wang Y; Wang G; Wang L; Ogden RT
    Biometrics; 2020 Jun; 76(2):427-437. PubMed ID: 31544958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predication of different stages of Alzheimer's disease using neighborhood component analysis and ensemble decision tree.
    Jin M; Deng W
    J Neurosci Methods; 2018 May; 302():35-41. PubMed ID: 29486213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-of-Interest based sparse feature learning method for Alzheimer's disease identification.
    Wang L; Liu Y; Zeng X; Cheng H; Wang Z; Wang Q
    Comput Methods Programs Biomed; 2020 Apr; 187():105290. PubMed ID: 31927305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
    Dyrba M; Grothe MJ; Mohammadi A; Binder H; Kirste T; Teipel SJ;
    J Alzheimers Dis; 2018; 65(3):731-746. PubMed ID: 28697557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-based mediation analysis in epigenetic studies.
    Fang R; Yang H; Gao Y; Cao H; Goode EL; Cui Y
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32608480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDENTIFICATION OF DISCRIMINATIVE IMAGING PROTEOMICS ASSOCIATIONS IN ALZHEIMER'S DISEASE VIA A NOVEL SPARSE CORRELATION MODEL.
    Yan J; Risacher SL; Nho K; Saykin AJ; Shen LI
    Pac Symp Biocomput; 2017; 22():94-104. PubMed ID: 27896965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying brain hierarchical structures associated with Alzheimer's disease using a regularized regression method with tree predictors.
    Zhao Y; Wang B; Liu CF; Faria AV; Miller MI; Caffo BS; Luo X
    Biometrics; 2023 Sep; 79(3):2333-2345. PubMed ID: 36263865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.